20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine." A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
Bullish:
Traders who believe that PetMeds will be able to handle the competition might want to consider the following trades:
- PetMeds (NASDAQ: PETS) The obvious trade here is to buy PetMeds
- A short on some competetiors such as Target (NYSE: TGT) as a potential increase in business could negatively affect PetMeds' competitors
Traders who believe that PetMeds' competitors will have a negative effect on their business may consider an alternate position:
- A short on Petmeds (NASDAQ: PETS) as the loss of business due to competitors could drive the stock down.
- Target (NYSE: TGT) as the business gained could from PetMeds could have positive effects and create a better outlook by investors, driving the stock up Neither Benzinga nor its staff recommend that you buy, sell, or hold any security. We do not offer investment advice, personalized or otherwise. Benzinga recommends that you conduct your own due diligence and consult a certified financial professional for personalized advice about your financial situation.
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine." A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!